ANGPTL8 has emerged as a central regulator of glucose and lipid metabolism, and its dysregulation has been associated with various cardio-metabolic disorders, including obesity, insulin resistance and dyslipidaemia (14, 15). The gene discussed is ANGPTL8; the disease is Insulin resistance.